- Home
- ZDGE vs CTSO Comparison
ZDGE vs CTSO Comparison
Compare ZDGE & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZDGE
- CTSO
- Stock Information
- Founded
- ZDGE 2008
- CTSO 1997
- Country
- ZDGE United States
- CTSO United States
- Employees
- ZDGE N/A
- CTSO N/A
- Industry
- ZDGE Computer Software: Prepackaged Software
- CTSO Medical/Dental Instruments
- Sector
- ZDGE Technology
- CTSO Health Care
- Exchange
- ZDGE Nasdaq
- CTSO Nasdaq
- Market Cap
- ZDGE 50.5M
- CTSO 51.6M
- IPO Year
- ZDGE N/A
- CTSO N/A
- Fundamental
- Price
- ZDGE $2.69
- CTSO $1.03
- Analyst Decision
- ZDGE
- CTSO Strong Buy
- Analyst Count
- ZDGE 0
- CTSO 3
- Target Price
- ZDGE N/A
- CTSO $4.67
- AVG Volume (30 Days)
- ZDGE 211.0K
- CTSO 538.8K
- Earning Date
- ZDGE 03-14-2025
- CTSO 03-06-2025
- Dividend Yield
- ZDGE N/A
- CTSO N/A
- EPS Growth
- ZDGE N/A
- CTSO N/A
- EPS
- ZDGE N/A
- CTSO N/A
- Revenue
- ZDGE $30,204,000.00
- CTSO $37,739,531.00
- Revenue This Year
- ZDGE $0.34
- CTSO $9.20
- Revenue Next Year
- ZDGE $6.35
- CTSO $11.64
- P/E Ratio
- ZDGE N/A
- CTSO N/A
- Revenue Growth
- ZDGE 10.15
- CTSO 1.80
- 52 Week Low
- ZDGE $1.93
- CTSO $0.70
- 52 Week High
- ZDGE $5.18
- CTSO $1.59
- Technical
- Relative Strength Index (RSI)
- ZDGE 50.88
- CTSO 55.82
- Support Level
- ZDGE $2.42
- CTSO $1.00
- Resistance Level
- ZDGE $2.83
- CTSO $1.14
- Average True Range (ATR)
- ZDGE 0.20
- CTSO 0.09
- MACD
- ZDGE 0.02
- CTSO 0.01
- Stochastic Oscillator
- ZDGE 33.13
- CTSO 64.40
About ZDGE Zedge Inc. Class B
Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.